Detalles de la búsqueda
1.
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Cell
; 142(5): 699-713, 2010 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20813259
2.
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience.
Ann Hematol
; 103(1): 321-334, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971549
3.
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Haematologica
; 108(1): 110-121, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770532
4.
Age, CD34+ cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.
Vox Sang
; 118(8): 681-689, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356813
5.
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
Eur J Haematol
; 111(1): 146-153, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058419
6.
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 196(3): 589-598, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34632572
7.
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Histopathology
; 81(6): 826-840, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109172
8.
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study.
Haematologica
; 107(2): 500-509, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134469
9.
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Ann Hematol
; 100(4): 1023-1029, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32367180
10.
Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Eur J Haematol
; 106(5): 697-707, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570765
11.
[Features of patients admitted for COVID-19 at a regional hospital in the Chilean Araucania Region]. / Características clínicas de pacientes ingresados por COVID-19 en un Hospital de alta complejidad de la región de la Araucanía-Chile.
Rev Med Chil
; 149(11): 1552-1560, 2021 Nov.
Artículo
en Español
| MEDLINE | ID: mdl-35735317
12.
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
Ann Hematol
; 99(1): 157-165, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844931
13.
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive Approach.
Mycopathologia
; 185(4): 639-652, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564177
14.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548583
15.
Do Patients and Physicians Agree When They Assess Quality of Life?
Biol Blood Marrow Transplant
; 23(6): 1005-1010, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28288950
16.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Biol Blood Marrow Transplant
; 23(1): 53-59, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27771496
17.
Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.
J Transl Med
; 15(1): 115, 2017 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549432
18.
Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
Ann Hematol
; 96(5): 787-796, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28168350
19.
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.
Ann Hematol
; 96(4): 639-646, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28101592
20.
Marginal zone lymphoma under anti-TNF treatment in Crohn disease. / Linfoma no Hodgkin nodal de zona marginal bajo tratamiento anti-TNF en enfermedad de Crohn.
Gastroenterol Hepatol
; 45(5): 390-391, 2022 05.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-34118314